EKEN, A. Et Al. 2018. S1P(1) receptor antagonists Fingolimod and SEW2871 affect human group 1 and 3 innate lymphoid cell biology. 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) , (Berlin, Germany), 395.

EKEN, A., YETKİN, M. F., Okus, F. Z., Erdem, S., ÇAKIR, M., Kutuk, M. S., ... VURAL, A.(2018). S1P(1) receptor antagonists Fingolimod and SEW2871 affect human group 1 and 3 innate lymphoid cell biology . 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) (pp.395). Berlin, Germany

EKEN, Ayşe Et Al. "S1P(1) receptor antagonists Fingolimod and SEW2871 affect human group 1 and 3 innate lymphoid cell biology," 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, Germany, 2018

EKEN, Ayşe Et Al. "S1P(1) receptor antagonists Fingolimod and SEW2871 affect human group 1 and 3 innate lymphoid cell biology." 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) , Berlin, Germany, pp.395, 2018

EKEN, A. Et Al. (2018) . "S1P(1) receptor antagonists Fingolimod and SEW2871 affect human group 1 and 3 innate lymphoid cell biology." 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) , Berlin, Germany, p.395.

@conferencepaper{conferencepaper, author={Ayşe EKEN Et Al. }, title={S1P(1) receptor antagonists Fingolimod and SEW2871 affect human group 1 and 3 innate lymphoid cell biology}, congress name={34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)}, city={Berlin}, country={Germany}, year={2018}, pages={395} }